ARVN Arvinas, Inc.
Arvinas, Inc. (ARVN) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $110.7K.
Where they traded
Last open-market purchase: March 6, 2026 , by Morrison Briggs .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Saik Andrew | Chief Financial Officer | Sell | 5,696 | $8.16 | $46.5K | 187,432 −2.9% of holding | |
| Cacace Angela M | Chief Scientific Officer | Sell | 2,576 | $7.59 | $19.6K | 180,390 −1.4% of holding | |
| Teel Randy | President and CEO | Sell | 2,209 | $9.04 | $20.0K | 285,009 −0.8% of holding | |
| Saik Andrew | Chief Financial Officer | Sell | 11,139 | $9.94 | $110.7K | 193,128 −5.5% of holding | |
| Berkowitz Noah | Chief Medical Officer | Sell | 11,108 | $9.94 | $110.4K | 191,395 −5.5% of holding | |
| Teel Randy | President and CEO | Sell | 9,657 | $9.94 | $96.0K | 287,218 −3.3% of holding | |
| Cacace Angela M | Chief Scientific Officer | Sell | 9,657 | $9.94 | $96.0K | 182,966 −5% of holding | |
| Loomis David K | VP, Chief Accounting Officer | Sell | 1,919 | $9.94 | $19.1K | 40,193 −4.6% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.